Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

PURPOSE: Our previous study showed that hepatic arterial infusion chemotherapy (HAIC) using oxaliplatin, fluorouracil, and leucovorin (FOLFOX) plus sorafenib provided a significant survival benefit over sorafenib for advanced hepatocellular carcinoma. However, it is unclear whether the survival bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Run-Bin, Zhao, Yang, He, Min-Ke, Wen, Dong-Sheng, Bu, Xiao-Yun, Huang, Ye-Xing, Lai, Zhi-Cheng, Xu, Yu-Jie, Kan, Anna, Wei, Wei, Zhang, Yao-Jun, Chen, Min-Shan, Guo, Rong-Ping, Li, Qi-Jiong, Shi, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149911/
https://www.ncbi.nlm.nih.gov/pubmed/34055599
http://dx.doi.org/10.3389/fonc.2021.619461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149911/
https://www.ncbi.nlm.nih.gov/pubmed/34055599
http://dx.doi.org/10.3389/fonc.2021.619461

Ejemplares similares